EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Houlihan Lokey, Inc.
EL7 Factor Analysis
How we score this
Overall67
Strong — clearly above market medianFalling StarF 5/8Better than 67% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
37
22.8x▼17.8xBottom tier
▸
Growth
60
1.7%▼7.1%Around median
▸
Quality
91
——Top tier
▸
Safety
75
——Top tier
▸
Capital Return
62
1.95%▼2.12%Around median
▸
Momentum
14
-35.0%▼2.9%Bottom tier
▸
Sentiment
90
7▲3Top tier
HLI

HLI Houlihan Lokey, Inc.

Houlihan Lokey, Inc. · NYSE
Market Closed
136.61
▲ ⁦+0.47%⁩ (+0.64)
Market Cap$9.5B
Beta0.97
52w Low52w High
112.83211.78
Last Week
⁦+2.55%⁩
Last Month
⁦+5.90%⁩
Last 3 Months
⁦-6.28%⁩
Last Year
⁦-31.84%⁩
Fair Value
Current price$137
Analyst target · 4 analysts
$161
⁦+18%⁩
See it undervalued
Range ⁦$145–$187⁩
vs
DCF (estimate)
$121
⁦-12%⁩
Sees it slightly overvalued
⁦8.7⁩% discount · ⁦3⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$121–$161⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 4 analysts setting price target
$163.60
⁦+19.8%⁩
Current Price $136.61·Median $161.00
Low
$145.00
High
$187.00
Current price
$136.61
Average target
$163.60
Street summary

Stable Targets with Clear Divergence Among Analysts

Price targets have not changed over the last 30 days; the consensus average remained at 163.6, despite the number of analysts increasing from 3 to 4 over the last 7 days and one day. Compared with the current price of 135.97, the consensus reflects an upside of approximately 20.3%, but the target range is wide, between 145 and 187, indicating notable divergence in valuations and uneven confidence.\n\nRecent ratings remain stable: UBS at Neutral and Morgan Stanley at Overweight, with no actual downgrade or upgrade. The estimates context includes a decline in average revenue and earnings per share for 2027 compared with 2026, followed by increases in both in 2028 and 2029, with very limited coverage for 2029, as only one analyst contributes to the average earnings per share. The overall picture is neutral: there has been no recent improvement in consensus, while the new coverage provides limited support and the dispersion score remains high.

As of 2026-09-10
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.64
Buy
Analyst coverage
⁦11 (+1)⁩
New coverage
Buy conviction
45%
Mixed
Target dispersion
31%
Wide
Analyst ratings over time11 analysts rating
2
3
6
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.50 → 3.64
Recent analyst moves
  • = Reiterate2026-07-08
    UBS
    Neutral
  • = Reiterate2026-05-07
    UBS
    —· $160.00
  • = Reiterate2026-04-09
    Morgan Stanley
    Overweight· $193.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    22.84x
    3.16x25.26x
    Near median
  • Forward P/E
    17.68x
    2.76x22.06x
    Expensive
  • EV / EBITDA
    —
    —
  • FCF Yield
    —
    —
  • Revenue Growth YoY
    1.7%
    -36.3%104.2%
    Below average
  • EPS Growth YoY
    -0.7%
    -99.4%194.2%
    Near median
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    1.9%
    0.6%9.0%
    Low
  • Payout Ratio
    44.9%
    9.8%97.8%
    Moderate
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-29 data

Company Overview

Houlihan Lokey operates as an advisory investment bank that generates revenue through three main businesses: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. Corporate Finance and Financial Restructuring depend heavily on transaction completions and the associated fee size, while Financial and Valuation Advisory benefits from a large number of fee events and valuation and data services; in Q1 fiscal 2027, this business recorded 1,042 fee events, compared with 957 in the comparable period.

In Q1 fiscal 2027, ended June 30, 2026, the company recorded revenue of $511.0 million, gross profit of $154.0 million, net income of $78.0 million, and GAAP earnings per share of $1.15. These figures equate to a gross profit margin of approximately 30.1% and a net income margin of approximately 15.3%, while management reported adjusted earnings per share of $1.35 and described the quarter's results as disappointing, but viewed them as a temporary disruption rather than a fundamental change in the long-term outlook.

Corporate Finance accounted for $303 million, or approximately 59.3% of Q1 fiscal 2027 revenue, but declined 24% year over year despite the number of closed transactions remaining nearly stable at 127, due to lower average fees and delays in larger transactions. Financial Restructuring generated $119 million with 23 closed transactions, while Financial and Valuation Advisory revenue rose 13% to $89 million, demonstrating the benefit of revenue diversification when middle-market M&A activity slowed.

What's Driving the Stock

  • Corporate Finance declined 24% to $303 million in Q1 fiscal 2027 because higher-fee transactions were delayed, while the number of closed transactions remained nearly stable at 127; therefore, improvement in results depends heavily on deferred transactions moving from the backlog to actual closing.
  • Technology activity across the company declined by approximately 54%, equivalent to $53 million during Q1 fiscal 2027, amid a reassessment of software transactions due to the potential effects of artificial intelligence and lower valuations, making it the largest specific numerical factor behind the quarter's weakness.
  • Financial Restructuring revenue totaled $119 million, and management expects activity to remain at elevated levels during fiscal 2027, supported by volatility in energy markets and disruption in private credit and software, despite the number of closed transactions declining 34% to 23.
  • Financial and Valuation Advisory grew 13% to $89 million, and the number of fee events rose 9% to 1,042. The company is also supporting this business with more advanced data tools and the joint CLO market benchmark with Morningstar, although management expects the collaboration to have little revenue impact at its current stage.
  • In Q1 fiscal 2027, Houlihan Lokey announced the acquisition of Intrepid Financial Partners, which specializes in the energy sector, with the transaction expected to close by the end of Q2 fiscal 2027 and add 32 employees, alongside the hiring of three new managing directors.
  • Insider data through August 3, 2026, showed one purchase and no sales, with three-month net activity of 500,570.40, providing a positive insider ownership signal within the available data without determining the course of operating performance.

Buying & Selling Case

▲ Buying Case4 pts

  • +Houlihan Lokey recorded revenue of $2.6 billion, net income of $425.7 million, and earnings per share of $6.22 in fiscal 2026, providing a substantial earnings base before the disruption in Q1 fiscal 2027.
  • +Despite weakness in Corporate Finance, management said the backlog, transaction pipeline, and new mandate activity were at record or strong levels and did not show the typical deterioration seen in recessionary markets, while the vast majority of deferred transactions were still progressing through the execution pipeline.
  • +The business mix provides a clear operating hedge; 13% growth in Financial and Valuation Advisory and Financial Restructuring revenue of $119 million partially offset the 24% decline in Corporate Finance in Q1 fiscal 2027.
  • +The acquisition of Intrepid Financial Partners and the addition of 32 employees could strengthen the company's presence in energy advisory, while investments in data and artificial intelligence are intended to expand the scope of valuation services and differentiate Houlihan Lokey from smaller advisory firms.

▼ Selling Case6 pts

Valuation

The analyst consensus is "Buy," with an average price target of $163.6 and a target range between $145 and $187. The average target is approximately 45.0% above the 52-week range low of $112.83, but approximately 22.7% below the high of $211.777, while the highest target remains approximately 11.7% below that high; this divergence reflects a balance between the strong backlog and the 24% decline in Corporate Finance and software disruption in Q1 fiscal 2027.

BuyAnalyst target: $163.6(+19.8%)

Figures in the text are as of 2026-08-29; the live price is shown at the top of the page.

FAQ

Why did HLI's results weaken in Q1 fiscal 2027?

Revenue totaled $511 million, and net income totaled $78 million, while GAAP earnings per share were $1.15 and adjusted earnings per share were $1.35. The main reason was a 24% decline in Corporate Finance revenue to $303 million due to delays in higher-fee transactions and lower average fees, despite the number of closed transactions remaining nearly stable at 127. Technology activity also declined by approximately 54%, or $53 million, amid a reassessment of software transactions due to artificial intelligence and lower valuations.

Does the backlog indicate a recovery in Houlihan Lokey transactions?

Management said on the July 29, 2026 call that the backlog, transaction pipeline, and new mandate activity in Corporate Finance were at record or strong levels, and that the vast majority of deferred transactions were still progressing. Cancellation and suspension rates also did not increase materially, and the proportion of transactions entering the market continued to improve. However, management did not specify when the middle market would return to normal and explained that closings could remain uneven over the near term.

How do the restructuring and valuation businesses offset weakness in Corporate Finance?
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • −Approximately 59.3% of Q1 fiscal 2027 revenue depends on Corporate Finance, and this business declined 24% to $303 million; therefore, overall performance remains highly sensitive to the timing of middle-market M&A transaction closings.
  • −Technology activity declined by approximately 54%, or $53 million, during Q1 fiscal 2027 due to the reassessment of software transactions in light of artificial intelligence and lower valuations, and this disruption may continue to weaken Corporate Finance even if Financial Restructuring later benefits from pressure on highly leveraged software companies.
  • −The number of closed Corporate Finance transactions remained nearly unchanged at 127, but average fees declined sharply because delays disproportionately affected larger transactions; this means that transaction volume stability alone does not guarantee a recovery in revenue or earnings.
  • −Management did not specify when the middle-market M&A market would return to normal conditions and said closings could remain uneven in the near term. The impact of geopolitical disruptions also began to ease in June and July 2026 but remained vulnerable to reversal amid renewed war in the Middle East.
  • −Adjusted non-compensation expenses rose 6% to $100 million, while management expects them to grow in fiscal 2027 at a rate similar to the prior year. It also expects an adjusted effective tax rate of between 26% and 28% after it reached 13% in the quarter, compared with negative 1% in the comparable period; this could pressure earnings if the revenue recovery is delayed.
  • −The average analyst target was $163.6, approximately 22.7% below the 52-week range high of $211.777, while the highest target of $187 remains below that high; therefore, a return of the stock to the upper levels of its historical range presents valuation risk unless the backlog converts into revenue and fees from large transactions recover.
  • Financial Restructuring generated revenue of $119 million in Q1 fiscal 2027, despite the number of closed transactions declining 34% to 23, because average fees on closed transactions increased. Management expects activity to remain at elevated levels during fiscal 2027, supported by energy, private credit, and software. At the same time, Financial and Valuation Advisory grew 13% to $89 million, with fee events rising 9% to 1,042.

    What is the significance of HLI's acquisition of Intrepid Financial Partners?

    Houlihan Lokey announced the acquisition of Intrepid Financial Partners during Q1 fiscal 2027 and described it as an independent investment bank specializing in the energy sector. The company expects to close the transaction by the end of Q2 fiscal 2027 and add 32 employees to the organization. Management believes the combination of the two organizations has already begun to support momentum in the energy business, alongside the continued strength of the company's acquisition pipeline.

    How could artificial intelligence affect HLI's business?

    The direct negative impact appeared in Q1 fiscal 2027, when the reassessment of software companies contributed to an approximately 54%, or $53 million, decline in technology activity. Conversely, management believes artificial intelligence can improve business efficiency and expand the market for valuation services, as the use of the technology in some portfolio valuation services reduced the price per valuation while increasing the number and frequency of valuations. The company is also using more advanced data tools and its collaboration with Morningstar to build a joint CLO market benchmark, but management said revenue from this collaboration would be minimal at its current stage.

    What are the key figures for valuing HLI stock?

    The average analyst price target is $163.6, with a low target of $145 and a high target of $187, and an overall consensus rating of "Buy." The 52-week range extends from $112.83 to $211.777, and the average target is approximately 22.7% below the top of the range, while the highest target is approximately 11.7% below it. The positive case is based on the strength of the backlog and business diversification, while the cautious case is based on the 24% decline in Corporate Finance and the 54% decline in technology activity in Q1 fiscal 2027.